J. D. Alder

455 total citations
20 papers, 358 citations indexed

About

J. D. Alder is a scholar working on Molecular Biology, Epidemiology and Organic Chemistry. According to data from OpenAlex, J. D. Alder has authored 20 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Organic Chemistry. Recurrent topics in J. D. Alder's work include Syphilis Diagnosis and Treatment (5 papers), Cancer therapeutics and mechanisms (5 papers) and Pneumonia and Respiratory Infections (3 papers). J. D. Alder is often cited by papers focused on Syphilis Diagnosis and Treatment (5 papers), Cancer therapeutics and mechanisms (5 papers) and Pneumonia and Respiratory Infections (3 papers). J. D. Alder collaborates with scholars based in United States, United Kingdom and Poland. J. D. Alder's co-authors include Ronald F. Schell, Jacob J. Clement, John L. Schmitz, Steven D. Lovrich, Steven M. Callister, S. Ken Tanaka, Joseph S. Solomkin, Diane M. Citron, Ellie J. C. Goldstein and B M Steiner and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

J. D. Alder

20 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. D. Alder United States	13	112	106	104	68	67	20	358
F. Chau France	14	54 0.5×	78 0.7×	88 0.8×	25 0.4×	190 2.8×	26	423
A. A. McColm United Kingdom	13	67 0.6×	45 0.4×	43 0.4×	10 0.1×	94 1.4×	25	378
Máximo B. Martínez Mexico	6	158 1.4×	109 1.0×	111 1.1×	31 0.5×	45 0.7×	7	329
Noa Tejman-Yarden Israel	7	109 1.0×	72 0.7×	169 1.6×	27 0.4×	48 0.7×	9	328
Els W. M. van Etten Netherlands	11	219 2.0×	98 0.9×	16 0.2×	31 0.5×	147 2.2×	15	423
Mohan Rao Malaysia	8	131 1.2×	167 1.6×	23 0.2×	33 0.5×	44 0.7×	13	366
Fernando Anaya-Velázquez Mexico	11	375 3.3×	98 0.9×	245 2.4×	31 0.5×	28 0.4×	45	545
Cátia Lacerda Sodré Brazil	11	102 0.9×	104 1.0×	25 0.2×	47 0.7×	174 2.6×	19	317
Simon Paul United States	6	224 2.0×	148 1.4×	45 0.4×	22 0.3×	288 4.3×	8	465
Sven‐Kevin Hotop Germany	9	81 0.7×	114 1.1×	17 0.2×	19 0.3×	81 1.2×	19	301

Countries citing papers authored by J. D. Alder

Since Specialization

Citations

This map shows the geographic impact of J. D. Alder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. D. Alder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. D. Alder more than expected).

Fields of papers citing papers by J. D. Alder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. D. Alder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. D. Alder. The network helps show where J. D. Alder may publish in the future.

Co-authorship network of co-authors of J. D. Alder

This figure shows the co-authorship network connecting the top 25 collaborators of J. D. Alder. A scholar is included among the top collaborators of J. D. Alder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. D. Alder. J. D. Alder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goldstein, Ellie J. C., Joseph S. Solomkin, Diane M. Citron, & J. D. Alder. (2011). Clinical Efficacy and Correlation of Clinical Outcomes With In Vitro Susceptibility for Anaerobic Bacteria in Patients With Complicated Intra-abdominal Infections Treated With Moxifloxacin. Clinical Infectious Diseases. 53(11). 1074–1080. 29 indexed citations

Wu‐Wong, Jinshyun R., J. D. Alder, D.J.W. Burns, et al.. (2001). Identification and characterization of A-105972, an antineoplastic agent.. PubMed. 61(4). 1486–92. 22 indexed citations

Mitten, Michael J., Jonathan A. Meulbroek, Anatol Oleksijew, et al.. (2001). Efficacies of ABT-773, a New Ketolide, against Experimental Bacterial Infections. Antimicrobial Agents and Chemotherapy. 45(9). 2585–2593. 24 indexed citations

Alder, J. D., Patty J. Ewing, Angela M. Nilius, et al.. (1998). Dynamics of Clarithromycin and Azithromycin Efficacies against ExperimentalHaemophilus influenzaePulmonary Infection. Antimicrobial Agents and Chemotherapy. 42(9). 2385–2390. 11 indexed citations

Alder, J. D., et al.. (1996). Preclinical in vivo efficacy of two 9-dihydrotaxane analogues against human and murine tumours. British Journal of Cancer. 73(5). 560–564. 8 indexed citations

Mitten, Michael J., et al.. (1996). Model of Streptococcus pneumoniae meningitis in adult rats.. PubMed. 46(5). 524–9. 4 indexed citations

Clement, Jacob J., et al.. (1995). Biological characterization of a novel antitumor quinolone.. PubMed. 55(4). 830–5. 28 indexed citations

Alder, J. D., et al.. (1994). Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.. PubMed. 20(11). 1141–8. 12 indexed citations

Clement, Jacob J., S. Ken Tanaka, J. D. Alder, et al.. (1994). In vitro and in vivo evaluations of A-80556, a new fluoroquinolone. Antimicrobial Agents and Chemotherapy. 38(5). 1071–1078. 19 indexed citations

10.

CHU, D. T. W., et al.. (1994). Synthesis and antitumour activities of tetracyclic quinolone antineoplastic agents.. PubMed. 20(5). 177–83. 20 indexed citations

11.

Lim, L C, et al.. (1993). Induction of Interleukin-1 Release by High- and Low-Passage Isolates of Borrelia burgdorferi. The Journal of Infectious Diseases. 167(5). 1086–1092. 22 indexed citations

12.

Alder, J. D., et al.. (1993). Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo. Antimicrobial Agents and Chemotherapy. 37(6). 1329–1333. 19 indexed citations

13.

Alder, J. D., et al.. (1993). Clarithromycin therapy of experimental Treponema pallidum infections in hamsters. Antimicrobial Agents and Chemotherapy. 37(4). 864–867. 6 indexed citations

14.

Clement, Jacob J., et al.. (1992). Synthesis and antitumour activities of quinolone antineoplastic agents.. PubMed. 18(7). 275–82. 31 indexed citations

15.

Alder, J. D., et al.. (1991). Role of L3T4+ and 38+ T-cell subsets in resistance against infection with Treponema pallidum subsp. pertenue in hamsters. Infection and Immunity. 59(2). 529–536. 10 indexed citations

16.

Lovrich, Steven D., Steven M. Callister, John L. Schmitz, J. D. Alder, & Ronald F. Schell. (1991). Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete. Infection and Immunity. 59(8). 2522–2528. 44 indexed citations

17.

Alder, J. D., et al.. (1990). Phagocytosis of opsonized Treponema pallidum subsp. pallidum proceeds slowly. Infection and Immunity. 58(5). 1167–1173. 22 indexed citations

18.

Steiner, B M, et al.. (1990). Immune T cells sorted by flow cytometry confer protection against infection with Treponema pallidum subsp. pertenue in hamsters. Infection and Immunity. 58(6). 1685–1690. 14 indexed citations

19.

Alder, J. D., et al.. (1989). Phagocytosis of Treponema pallidum pertenue by Hamster Macrophages on Membrane Filters. The Journal of Infectious Diseases. 160(2). 289–297. 11 indexed citations

20.

Alder, J. D., et al.. (1987). Plasmodium berghei malaria: effect of acute phase serum on immunity generated in rats by infection and by vaccination. Parasitology Research. 74(2). 116–122. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact